- 12:07 PM Rupee gives up gains after touching 1-wk high
- 12:04 PM Hindalco Industries leads gainers on Sensex
- 11:58 AM Geojit BNP Paribas derivative analysis
- 11:51 AM SBI says 20% credit growth difficult to achieve
- 11:50 AM Geojit BNP Paribas market report
- 11:47 AM Infotech Ent plans 2 acquisitions in US, stock up
- 11:46 AM Asian Hotels sees improved occupancies, ARR Nov on...
- 11:46 AM TVS Motor looks expensive: Baliga
- 11:42 AM Buy rupee with stoploss at 46.18: RR Financial
- 11:42 AM HeidelbergCement looks expensive: Baliga



Q: How might the market take the news (Ranbaxy recalls 73 m pills of Gabapentin in US retail market after discovering impurities) on Ranbaxy this morning?
A: CNBC-TV18's stocks editor, Udayan Mukherjee - Not very well, not too badly either, because materially it may not mean too much for Ranbaxy, the size of the drug and what they recalling might not tend the revenues materially. But as a Ranbaxy investor, you would tend to worry a little bit about how the US FDA might look at all these things; remember the big cloud over Ranbaxy a few quarters back or throughout the last few quarters has been their Paonta Sahib facility, what the US FDA is going to do with it.
|
RSS feed for news |
And now for a large number of drugs have been pulled back because of impurities, maybe Ranbaxy comes a little bit more under the scanner of the US FDA. I would worry on that front on whether Ranbaxy is increasingly getting into a bit of a grey-list for the US FDA.
So that is the worry rather than the more material pullback or the revenue impact of this pullback.
|
|
Business
Business News | Economy | Earnings | BSE NSE Notices
General News
Current Affairs | Politics | World News | Sports | Entertainment
Corporate Strategy
Management | Advertising | Marketing | Legal
Personal Finance
Tax | Insurance | Credit Cards | Loans | Property | Retirement | Investment Help | Financial Planning | Fixed Income
Markets
Local Market | Global Market | Market Cues | Analysis | Expert & FII outlook | Brokerage Recomendation
Stocks
Stocks in News | Expert Advice | ADRs & GDRs | IPO
Mutual Funds
News | Advice | MF Analysis | Fund Managers Views
Lifestyle
Travel | Wellness | Technology | Auto| Books
-
Most Read
-
Most Viewed
- 10 Companies that FIIs love
- 10 companies that MF managers love
- Why Gates, Buffett are not giving up on US economy
- Expert stock/sector picks in these markets

- India to sell $70 bn shares in 3 years: Morgan Stanley
- Mahindra Satyam to declare audited nos by June 2010

- Sell Mahindra Satyam: Sandeep Wagle

- Ganeshaspeaks: Market prediction for Nov 26
- Ashwani Gujral's top five picks for today's trade

- Mahindra Satyam has good support at Rs 88: Mohindar

- Lanco Infra tying up funds for three power projects
Source: Business Line
- RIL units to get 20% of gas needs from D-6
Source: Business Line
- No need to ban cotton export, says Maran
Source: Business Line
- Karnataka hikes power tariff by 34.16 paise/unit
Source: Business Line










